Skip to content

Response to increased versus standard dose of oral Vitamin D in obese and overweight children 5 to 12 years of age.

Response to an increased dose versus standard dose of oral Vitamin D in Vitamin D deficient overweight and obese children - "An open labelled Randomised Controlled Trial". - nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055191
Enrollment
60
Registered
2023-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: response to an increased vs standard dose of oral vitamin d in vitamin d deficient overweight and obese children- an open labelled randomised controlled trial: participants will be rand

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: overweight / obese children of age 5-12 years presenting to the pediatric OPDof cnbc delhi will be screened and included in the study if their serum 25(OH) vitamin D levelks are less than 20ng/ml

Exclusion criteria

Exclusion criteria: 1) children with confirmed or suspected malabsorption, renal or hepatic disorders. 2) children who had received vitamin D in therapeutic doses in the last 6 months. 3) children who had received drugs that may interferev with vitamin D metabolism like anticonvulsants, steriods, chemotherapy, antitubercular, h2 blockers, and thiazide diuretics and those on any herbal or ayurvedic medicines. 4) children with any known systemic illness oer metabolic disroders known to be assiociated with obesity wither before or during study or subjects with sypmtosm s/o hypothalamic obesity like hypothyroidism, cushing syndrome etc.

Design outcomes

Primary

MeasureTime frame
to evaluate the rise in levels of serum 25(OH)D levels in each group from baseline to 30 days after the last dose of vitamin D.Timepoint: From baseline to 30 days post supplementation of oral Vitamin D .

Secondary

MeasureTime frame
secondary outcome: 1) to measure serum 25(OH)d levels at day 7 2)serum calcium levels post suplementation day 7 & 30 3) urinary calcium creatinine ratio levels post supplementation day 7 and day 30.Timepoint: day 7 & day 30 post supplmentation

Countries

India

Contacts

Public ContactDr.S.Adithya

Chacha Nehru Bal Chikitsalaya

goelmedha@gmail.com09599718219

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026